Open AccessPI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron
Author(s) -
Acharya Arpan,
Pathania Anup S.,
Pandey Kabita,
Thurman Michellie,
Vann Kendra R.,
Kutateladze Tatiana G.,
Challagundala Kishore B.,
Durden Donald L.,
Byrareddy Siddappa N.
Publication year - 2022
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.806
Subject(s) - discovery and development of mtor inhibitors , replication (statistics) , pi3k/akt/mtor pathway , covid-19 , medicine , virology , computational biology , genetics , biology , disease , infectious disease (medical specialty) , apoptosis